Following our insistent calls to expedite the processing of permit applications, the Anti-Red Tape Authority (ARTA) is pleased to learn that the Food and Drug Administration (FDA) has issued a License to Operate (LTO) for medicine trading to Dr. Allan Landrito, a vocal proponent of using Ivermectin to treat COVID-19. ARTA was informed about this.. read more
Statement of the Anti-Red Tape Authority on FDA’s Granting of Compassionate Special Permit to a Hospital for use of Ivermectin on Covid-19 patients
The Anti-Red Tape Authority (ARTA) welcomes the move of the Food and Drug Administration (FDA) for granting the application of a hospital for a Compassionate Special Permit to use Ivermectin on humans with COVID-19. With this, ARTA urges FDA to continue processing applications from other medical institutions seeking the same permit expeditiously while key agencies.. read more
ARTA asks FDA to keep their communications open for Ivermectin applications
31 March 2021 – Anti-Red Tape Authority (ARTA) Director General Jeremiah Belgica, in a meeting earlier, called on the Food and Drug Administration (FDA) to “keep their communications open for the registration of pharmaceutical companies who would want to apply for a Drug Emergency Use or a Compassionate Special Permit for Ivermectin”. During the meeting,.. read more